An interventional study of Digital Intervention and Health Education in Depression and Anxiety, sponsored by Adai Technology (Beijing) Co., Ltd.. Status unknown at 1 site in China. Open to participants aged 10 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-04-22.
Sponsored by Adai Technology (Beijing) Co., Ltd. · Not applicable, Interventional, and Treatment
The goal of this clinical trial is to evaluate the effectiveness of digital interventions in treating depression and anxiety in adolescents. The main question it aims to answer is: Can digital interventions effectively alleviate symptoms of depression and anxiety in adolescents? The trial will include a comparison group where researchers will compare the effects of the digital intervention to traditional health education methods to assess their relative efficacy.
Participants will be asked to engage with the digital intervention platform for a period of two months.
8,245 studies on the registry are indexed under Depression; 1,641 are open to participants now.
This study's planned enrollment of 100 is above the median of 84 across 6,869 interventional studies indexed under Depression.
Browse Depression studies →Adai Technology (Beijing) Co., Ltd. is the lead sponsor of 10 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Digital Intervention
Behavioral: Health Education
game-based digital intervention app
traditional health education app
Hamilton Depression Rating Scale
Score Range: 0 (best outcome) to 52 (worst outcome) Higher scores indicate worse depression symptoms.
Time frame: baseline and immediately after 8-week intervention
Hamilton Anxiety Rating Scale
Score Range: 0 (best outcome) to 56 (worst outcome) Higher scores indicate more severe anxiety symptoms.
Time frame: baseline and immediately after 8-week intervention
ADHD(attention deficit hyperactivity disorder) Rating Scale-IV
Score Range: 0 (best outcome) to 54 (worst outcome) Higher scores indicate more severe ADHD symptoms.
Time frame: baseline and immediately after 8-week intervention
PHQ-9 (Patient Health Questionnaire-9)
PHQ-9 Score Range: 0 (best outcome) to 27 (worst outcome); higher scores indicate more severe depression symptoms.
Time frame: baseline and weekly assessments during the treatment period, assessed up to 8 weeks
GAD-7 (Generalized Anxiety Disorder-7)
GAD-7 Score Range: 0 (best outcome) to 21 (worst outcome); higher scores indicate more severe generalized anxiety symptoms.
Time frame: baseline and weekly assessments during the treatment period, assessed up to 8 weeks
This study is status unknown, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Adai Technology (Beijing) Co., Ltd.